Close Menu

NEW YORK (GenomeWeb) – Color Genomics said this week in an SEC filing that it has raised $52 million thus far in a planned $80M funding round.

A company spokesperson added today that the financing is being led by General Catalyst, and also includes Emerson Collective and CRV.

According to Color CEO Othman Laraki, money raised in the round will be used to further invest in developing testing strategies for hereditary conditions, and to further other aspects of preventive medicine — focusing on areas where "the science is clear and the results are actionable."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.